Quince Therapeutics, Inc.
Status: Publicly traded
Direct answer
Quince Therapeutics, Inc. is publicly traded on NASDAQ under the ticker QNCX.
Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease...
Can you invest in Quince Therapeutics, Inc.?
Yes. Quince Therapeutics, Inc. is publicly traded on NASDAQ under the ticker QNCX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Quince Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.